On January 4, 2022, the White House Office of Science and Technology Policy (OSTP) released the report, “Guidance for Implementing National Security Presidential Memorandum 33…
In December of 2021, the FDA released a Draft Guidance document on “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations.” Clinical trials may…
On December 9, 2021, the U.S. Food and Drug Administration (FDA) released draft guidance entitled “Considerations for the Use of Real-World Data and Real-World Evidence…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
In October 2021, the National Institutes of Health (NIH) announced the launch of the Bespoke Gene Therapy Consortium (BGTC), part of their Accelerating Medicines Partnership…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
On January 31, 2022, the new European Medicines Agency (EMA) Clinical Trials Regulation (Regulation (EU) No 536 / 2014) comes into effect according to the…
As of January 2, 2022, institutions will be required to submit OHRP incident reports, electronically, via the new online form (unless they are unable to…
MITRE and the Medical Device Innovation Consortium (MDIC), with funding by the U.S. Food and Drug Administration (FDA), has released “Playbook for Threat Modeling Medical…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
